Method development and validation of raltegravir by RP-HPLC method
DOI:
https://doi.org/10.61096/ijpar.v8.iss3.2019.320-328Keywords:
Raltegravir, HPLC, Method Development, ICH, Validation, Accuracy, Precision.Abstract
Objective
The objective of the present research work was to develop an innovative, simple, and economic method for estimation of Raltegravir in bulk and dosage form by RP-HPLC.
Methods
The chromatographic conditions were performed on Symmetry Develosil ODS HG-5 RP C18, 5mm, 15cmx4.6mm i.d. as stationary phase and mobile phase was prepared with a mixture of Phosphate buffer (pH=3.0) : Methanol with 30:70, flow 1.0 ml/min, with Injection Volume 10µl, at detection wavelength 246 nm and run time at 5.0 min.
Results
The analytical method is valid for estimation of Raltegravir over a range of 20 µg/ml–70 µg/ml. The results of system suitability test, linearity, precision and accuracy, robustness, specificity, LOD and LOQ and stabilities presented in this report are within the acceptance range.
Conclusion
A specific, sensitive, economic method estimation of Raltegravir has been developed based on ICH Guidelines with bulk and dosage forms.